New Zealand markets closed

LLY Jan 2026 820.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
124.960.00 (0.00%)
As of 12:07PM EST. Market open.
Full screen
Previous close124.96
Open135.22
Bid0.00
Ask0.00
Strike820.00
Expiry date2026-01-16
Day's range124.90 - 124.96
Contract rangeN/A
Volume2
Open interest14
  • Insider Monkey

    20 Fastest Growing Biotech Companies in the US

    In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]

  • Zacks

    Zacks Market Edge Highlights: AAPL, COST, WSM, LLY and HLT

    AAPL, COST, WSM, LLY and HLT have been highlighted in this Market Edge article.

  • Reuters

    Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

    The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost workplace efficiency, according to Goldman Sachs. Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday.